Available to watch now - Functional genomic approaches to guide cancer drug discovery

Dr Garnett is a Group Leader at the Wellcome Sanger Institute in the Cancer, Ageing and Somatic Mutation programme. He and his team investigate how genetic alterations contribute to cancer and impact on patient responses to anti-cancer medicines.

Dan Ross

COVID-19 research at the Sanger Institute

We are committed to tracking, understanding and combatting COVID-19. Our staff sequence thousands of virus genomes and use the data to trace transmission, inform public health measures and monitor for new variants of the virus. We also work to understand how the virus interacts with our cells, and to develop new diagnostics

Connect with us on Twitter

📣Pf6 data release is the world's largest open resource of genomic data on #malaria parasites.

👀The data provides benchmark data on parasite genome variation. #malariagenomics #MalariaSurveillance

Read about #Plasmodium #falciparum version 6 data:

http://bit.ly/3aMpNHw

Image for the Tweet beginning: 📣Pf6 data release is the

🚨The latest version of the Open Targets Platform — 21.02 — is now available!

🦠We also have an update of our Covid-19 prioritisation tool

👇Full details on the blog, or keep reading for a quick recap

http://blog.opentargets.org/2021/02/17/open-targets-platform-21-02-release/

Ever wondered how your #Covid19 swabs are helping scientists?

@SangerInstitute researchers are using test samples to identify emerging variants and pinpoint outbreaks 🎥 ⤵️

Image for the Tweet beginning: Ever wondered how your #Covid19